{
  "figure_1": "The pathway of drugs targeting HER2 for the treatment of HER2+ breast cancer.",
  "figure_2": "Function of the PI3K/AKT pathway and its involvement in anti-HER2 treatment resistance. HER2, human epidermal growth factor receptor 2; PI3K, phosphoinositide 3-kinase; HER2-HET, HER2-heterogeneous; DPAGT1, dolichyl-phosphate N-acetylglucosaminephosphotransferase 1; ECD, extracellular domain; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3, phosphatidylinositol-3,4,5-trisphosphate; PTEN, phosphatase and tension homolog; mTORC, mammalian target of rapamycin complex; TSC, tuberous sclerosis complex; 4EBP1, eukaryotic translation initiation factor 4E-binding protein 1; S6K, ribosomal protein S6 kinase; FOXO, forkhead box O; FOXM1, forkhead box protein M1; ALDH, aldehyde dehydrogenase; IL-8, interleukin-8; CSC, cancer stem cell; GSK-3β, glycogen synthase kinase 3 beta; GPCPD1, glycerophosphodiesterase 1; TSPAN8, tetraspanin-8; STAT3, signal transducer and activator of transcription 3; IKK, inhibitor of kappa B kinase; MDM2, murine double minute 2; BAD, BCL2-associated agonist of cell death; Bcl-2, B-cell lymphoma 2; BCL-XL, B-cell lymphoma-extra-large; MYC, myelocytomatosis oncogene; MMP9, matrix metalloproteinase-9.",
  "figure_3": "The role of the PI3K/AKT pathway in the resistance to anti-HER2 therapy with crosstalk of other signaling pathways. HER2, human epidermal growth factor receptor 2; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3, phosphatidylinositol-3,4,5-trisphosphate; PTEN, phosphatase and tension homolog; mTORC, mammalian target of rapamycin complex; CDK4/6, Cyclin-dependent kinases 4 and 6; ER, estrogen receptor; 14,15-EET, 14,15-Epoxyeicosatrienoic acid; GRB7, growth factor receptor-bound protein 7; FAK, focal adhesion kinase; Rb, retinoblastoma protein; AXL, AXL receptor tyrosine kinase; EMT, epithelial–mesenchymal transition; GAS6, growth arrest-specific 6; IGF-1R, insulin-like growth factor 1 receptor; IRS1, insulin receptor substrate; HER3, human epidermal growth factor receptor 3; STAT6, signal transducer and activator of transcription 6; HDAC, histone deacetylase; PPP3CB, protein phosphatase 3 catalytic subunit beta; FOXO, forkhead box O; TGFβ, transforming growth factor-beta; SMAD3, mothers against decapentaplegic homolog 3; PCBP1, Poly (C)-binding protein 1; SCF, Skp, Cullin, F-box-containing complex; Skp2, S-phase kinase-associated protein 2."
}